The UK pharma and biotech industries have warned that clarity on Brexit arrangements for medicines is needed urgently - but no deal is in sight just 13 months ahead of its official departur
Today could be a major turning point for the UK biotech sector, as changes in government policy could help channel billions of new investment into drug discovery and development.